OncoLink at ASCO 1996: Tuesday, May 21

photo of Fauzia Rana and Naheed Usmani, from Shaukat Knanum Mem. Hosp., Lahore, Pakistan

Photo (l to r): Fauzia Rana, MD and Naheed Usmani, MD. Shaukat Khanum Memorial Hospital, Lahore, Pakistan

A Clinical Trial Of Antigen-Pulsed Dendritic Cells (DC) In The Treatment Of Patients With B-Cell Lymphoma Researchers at Stanford University Medical Center presented preliminary results of a study on a new vaccine treatment for B-cell lymphoma. Chemotherapy and/or radiation can cause remission in most patients with B-cell lymphoma. However, despite...
Clinical Benefits versus Quality of Life of Patients Receiving Interferon Bernard Cole, Ph.D., assistant professor of community health (Research), Center for Statistical Science, Brown University (Providence, RI), presented an analysis of the quality of life of melanoma patients receiving interferon alfa-2b therapy...
Immediate Hormonal Therapy Improves Survival In Patients With Locally Advanced Prostate Cancer Michel Bolla, M.D., professor of radiation oncology, University Joseph Fourier Grenoble (Grenoble, France) presented a study which aimed to increase the survival of patients suffering from locally advanced prostate cancers by combining radiation...
Interferon Therapy Delays Disease Recurrence and Prolongs Survival in Patients with Resected Melanoma Jean-Jacques Grob, MD, professor dermatology, University of Marseille, Hopital Sante-Marguerite (Marseille, France), presented a study of interferon alfa-2a as adjuvant therapy in patients with resected (surgically removed) early stage melanoma....
Patterns of Care for Women with Ovarian Cancer in the United States Michel Bolla, M.D., professor of radiation oncology, University Joseph Fourier Grenoble (Grenoble, France) presented a study which aimed to increase the survival of patients suffering from locally advanced prostate cancers by combining radiation...
Phase I/II Trial Results Of 131-I-Anti-B1 (Anti-CD20) Non-Myeloablative Radioimmunotherapy For Refractory B-Cell Lymphoma Researchers at the University of Michigan Medical Center (Ann Arbor, MI) presented results of a Phase I/II clinical trial of a new form of treatment for non-Hodgkin's lymphoma. There are approximately 51,000 new cases of non-Hodgkin's lymphoma in...
Reduction of Skeletal Morbidity and Prevention of Bone Metastases with Oral Clodronate in Women with Recurrent Breast Cancer in the Absence of Skeletal Metastases A.H.G. Paterson, MD, head, Division of Medical Oncology, Department of Medicine, University of Calgary (Alberta, Canada), presented the results of a study which examined the effect of clodronate on the incidence of skeletal metastases and...
Superiority of Chemo-Radiotherapy Vs. Radiotherapy In Patients with Esophageal Cancer Arnold Herskovic, M.D., medical director, Radiation Oncology Department, Oakwood Hospital and Medical Center (Dearborn, MI), presented the results o a study which compared the overall survival of esophageal cancer patients treated with radiotherapy...
What PSA Nadir Level Should Be Achieved After Irradiation For Prostate Cancer? Arnold Herskovic, M.D., medical director, Radiation Oncology Department, Oakwood Hospital and Medical Center (Dearborn, MI), presented the results o a study which compared the overall survival of esophageal cancer patients treated with radiotherapy...